Work

Randomized Phase II/III Study of DA-EPOCH-R +/- Venetoclax in Previously Untreated Double Hit Lymphoma: Initial Results from Alliance A051701

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-151266

Authors: Jeremy S. Abramson, Amy S. Ruppert, Sharmila Giri, Ann Hudson, Eric D. Hsi, Richard F. Little, Steven D. Gore, Anusha Vallurupalli, Daniel J Landsburg, Brad S. Kahl, Jonathan W. Friedberg, Nancy L. Bartlett, John P. Leonard

Institutions: Massachusetts General Hospital, The Ohio State University, Mayo Clinic, Atrium Health Wake Forest Baptist, National Institutes of Health, National Cancer Institute, The University of Kansas Cancer Center, Hospital of the University of Pennsylvania, University of Pennsylvania, Washington University in St. Louis, Alvin J. Siteman Cancer Center, University of Rochester Medicine, University of Rochester, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3212372809

Cites:

Cited by: 28

Related to: 10